Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Obinutuzumab”

251 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 251 results

Testing effectiveness (Phase 2)Study completedNCT04880863
What this trial is testing

NAP in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pretreated Advanced or Metastatic NSCLC

Who this might be right for
Non-small Cell Lung Cancer
NeoTX Therapeutics Ltd. 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT02629809
What this trial is testing

Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
M.D. Anderson Cancer Center 81
Testing effectiveness (Phase 2)Study completedNCT02558816
What this trial is testing

A Trial of Obinutuzumab,GDC-0199 Plus Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma Patients

Who this might be right for
Mantle Cell Lymphoma
Nantes University Hospital 48
Testing effectiveness (Phase 2)Ended earlyNCT02225275
What this trial is testing

Lenalidomide and Obinutuzumab in Treating Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Recurrent Chronic Lymphocytic LeukemiaRecurrent Small Lymphocytic LymphomaRefractory Chronic Lymphocytic Leukemia+1 more
M.D. Anderson Cancer Center 9
Large-scale testing (Phase 3)Ended earlyNCT01980875
What this trial is testing

Efficacy and Safety of Idelalisib in Combination With Obinutuzumab Compared to Chlorambucil in Combination With Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Gilead Sciences 57
Testing effectiveness (Phase 2)Looking for participantsNCT06054776
What this trial is testing

Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
City of Hope Medical Center 40
Testing effectiveness (Phase 2)UnknownNCT06087419
What this trial is testing

A Prospective Clinical Study of Bridging alloHSCT After Treatment With Obinutuzumab in Combination With Chidamide and Venetoclax in RR Ph-ALL and B-cell Lymphoma Patients

Who this might be right for
Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China 42
Testing effectiveness (Phase 2)Looking for participantsNCT05039619
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

Who this might be right for
Lupus Nephritis
Hoffmann-La Roche 40
Not applicableUnknownNCT05845762
What this trial is testing

Obinutuzumab in the Management of Idiopathic Membranous Nephropathy

Who this might be right for
Idiopathic Membranous Nephropathy
Qianfoshan Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06108232
What this trial is testing

Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma

Who this might be right for
Follicular LymphomaTumor
M.D. Anderson Cancer Center 36
Not applicableLooking for participantsNCT05846763
What this trial is testing

Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Follicular Lymphoma in Real World Study

Who this might be right for
Follicular Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT03533283
What this trial is testing

An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkins Lymphoma
Hoffmann-La Roche 211
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06324994
What this trial is testing

Linperlisib Plus Obinutuzumab and Venetoclax for Relapsed and Refractory Blastoid Variant of Mantle Cell Lymphoma.

Who this might be right for
Mantle Cell Lymphoma
Dalian Medical University 10
Early research (Phase 1)Ended earlyNCT01644253
What this trial is testing

Phase 1b Safety and Efficacy Study of TRU-016

Who this might be right for
Chronic Lymphocytic LeukemiaPeripheral T-cell Lymphoma
Aptevo Therapeutics 87
Post-approval studies (Phase 4)Study completedNCT03817853
What this trial is testing

An Open-Label, Single Arm Study of Obinutuzumab Short Duration Infusion in Patients With Previously Untreated Advanced Follicular Lymphoma

Who this might be right for
Advanced Follicular Lymphoma
Hoffmann-La Roche 114
Large-scale testing (Phase 3)Looking for participantsNCT04702256
What this trial is testing

Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF

Who this might be right for
Lupus NephritisSystemic Lupus Erythematosus (SLE)
Assistance Publique - Hôpitaux de Paris 196
Early research (Phase 1)Ended earlyNCT04073147
What this trial is testing

Venetoclax and Obinutuzumab for Relapsed/Refractory Primary CNS Lymphoma

Who this might be right for
Primary CNS Lymphoma
Klinikum Stuttgart 4
Early research (Phase 1)Study completedNCT00825149
What this trial is testing

Obinutuzumab in Combination With Chemotherapy in Participants With CD20+ B-Cell Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 137
Testing effectiveness (Phase 2)Looking for participantsNCT04077723
What this trial is testing

Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Hoffmann-La Roche 498
Testing effectiveness (Phase 2)Study completedNCT02055820
What this trial is testing

A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax Combined With Chemotherapy in Participants With B-Cell Non-Hodgkin's Lymphoma (NHL) and DLBCL

Who this might be right for
Lymphoma, Non-Hodgkin
Hoffmann-La Roche 267
Load More Results